TLSA Earnings — Tiziana Life Sciences Ltd. Common Shares Post-ER Performance | BigEarnings
TLSA — Tiziana Life Sciences Ltd. Common Shares
XNAS
Price$1.41
Market Cap$179.4M
P/E—
52W Range$1.14 – $2.60
About Tiziana Life Sciences Ltd. Common Shares
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
